TY - JOUR
T1 - Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity
AU - Scully, Paul
AU - McKernan, Declan P.
AU - Keohane, John
AU - Groeger, David
AU - Shanahan, Fergus
AU - Dinan, Timothy G.
AU - Quigley, Eamonn Martin
PY - 2010/10/1
Y1 - 2010/10/1
N2 - Objectives: Irritable bowel syndrome (IBS) is a functional disorder that is associated with a number of extra-intestinal co-morbidities and a pro-inflammatory profile. This study was designed to examine the cytokine profile among a group of IBS patients with the extra-intestinal co-morbidities fibromyalgia, premenstrual dysmorphic disorder, and chronic fatigue syndrome. Methods: In all, 100 female IBS patients with these co-morbidities, 21 IBS subjects without co-morbidity (pure IBS; Rome II), and 54 age-matched female controls took part in the study. Blood was drawn for measurement of the plasma cytokines interleukin (IL)-1Β, IL-6, IL-8, IL-10, IL-12p70, IL-13, tumor necrosis factor (TNF)α, and interferon γ. The presence of the selected extra-intestinal manifestations was assessed using standard international criteria. Results: Patients with IBS have increased plasma levels of IL-6 and IL-8; those with these extra-intestinal co-morbidities were found to have, in addition, increased levels of IL-1Β and TNFα. No associations were evident between cytokine profiles and the nature of the co-morbidity or number of extra-intestinal co-morbidities present. Conclusions: Although IBS is characterized by a pro-inflammatory profile featuring the pro-inflammatory cytokines IL-6 and IL-8, IBS patients with certain extra-intestinal co-morbid conditions are distinguished by additional elevations in IL-1Β and TNFα.
AB - Objectives: Irritable bowel syndrome (IBS) is a functional disorder that is associated with a number of extra-intestinal co-morbidities and a pro-inflammatory profile. This study was designed to examine the cytokine profile among a group of IBS patients with the extra-intestinal co-morbidities fibromyalgia, premenstrual dysmorphic disorder, and chronic fatigue syndrome. Methods: In all, 100 female IBS patients with these co-morbidities, 21 IBS subjects without co-morbidity (pure IBS; Rome II), and 54 age-matched female controls took part in the study. Blood was drawn for measurement of the plasma cytokines interleukin (IL)-1Β, IL-6, IL-8, IL-10, IL-12p70, IL-13, tumor necrosis factor (TNF)α, and interferon γ. The presence of the selected extra-intestinal manifestations was assessed using standard international criteria. Results: Patients with IBS have increased plasma levels of IL-6 and IL-8; those with these extra-intestinal co-morbidities were found to have, in addition, increased levels of IL-1Β and TNFα. No associations were evident between cytokine profiles and the nature of the co-morbidity or number of extra-intestinal co-morbidities present. Conclusions: Although IBS is characterized by a pro-inflammatory profile featuring the pro-inflammatory cytokines IL-6 and IL-8, IBS patients with certain extra-intestinal co-morbid conditions are distinguished by additional elevations in IL-1Β and TNFα.
UR - http://www.scopus.com/inward/record.url?scp=77957844957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957844957&partnerID=8YFLogxK
U2 - 10.1038/ajg.2010.159
DO - 10.1038/ajg.2010.159
M3 - Article
C2 - 20407431
AN - SCOPUS:77957844957
SN - 0002-9270
VL - 105
SP - 2235
EP - 2243
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 10
ER -